Alpine Global Management LLC Acquires New Position in Walgreens Boots Alliance, Inc. $WBA

Key Points

• Alpine Global Management LLC acquired a new stake in Walgreens Boots Alliance, purchasing 100,000 shares valued at approximately $1.1 million.
• Walgreens Boots Alliance reported quarterly earnings of $0.38 EPS, surpassing consensus estimates of $0.34, and experienced a revenue increase of 7.2% compared to the previous year.
• Wall Street analysts have mixed ratings on Walgreens Boots Alliance, with a consensus "Reduce" rating and an average target price of $10.15.

Alpine Global Management LLC bought a new position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) during the first quarter, according to its most recent filing with the SEC. The firm bought 100,000 shares of the pharmacy operator's stock, valued at approximately $1,117,000.

Several other large investors have also bought and sold shares of the stock. Charles Schwab Investment Management Inc. lifted its stake in Walgreens Boots Alliance by 10.8% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 14,580,827 shares of the pharmacy operator's stock valued at $162,868,000 after acquiring an additional 1,425,689 shares in the last quarter. Northern Trust Corp lifted its stake in Walgreens Boots Alliance by 18.8% during the 4th quarter. Northern Trust Corp now owns 8,896,742 shares of the pharmacy operator's stock valued at $83,007,000 after acquiring an additional 1,407,973 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in Walgreens Boots Alliance by 5.0% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,972,514 shares of the pharmacy operator's stock valued at $74,384,000 after acquiring an additional 378,039 shares in the last quarter. Two Sigma Advisers LP raised its stake in shares of Walgreens Boots Alliance by 186.3% during the 4th quarter. Two Sigma Advisers LP now owns 7,740,100 shares of the pharmacy operator's stock worth $72,215,000 after purchasing an additional 5,036,300 shares during the period. Finally, Deutsche Bank AG raised its stake in shares of Walgreens Boots Alliance by 23.5% during the 1st quarter. Deutsche Bank AG now owns 7,567,154 shares of the pharmacy operator's stock worth $84,525,000 after purchasing an additional 1,441,780 shares during the period. 58.59% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance Stock Performance

Shares of WBA stock remained flat at $11.98 during trading hours on Friday. The company has a market capitalization of $10.37 billion, a PE ratio of -1.64, a PEG ratio of 1.42 and a beta of 0.80. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $13.25. The firm has a 50-day moving average price of $11.74 and a 200 day moving average price of $11.31. The company has a quick ratio of 0.32, a current ratio of 0.60 and a debt-to-equity ratio of 0.96.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its quarterly earnings data on Thursday, June 26th. The pharmacy operator reported $0.38 EPS for the quarter, beating the consensus estimate of $0.34 by $0.04. The firm had revenue of $38.99 billion for the quarter, compared to the consensus estimate of $36.72 billion. Walgreens Boots Alliance had a negative net margin of 4.07% and a positive return on equity of 17.66%. The company's revenue was up 7.2% on a year-over-year basis. During the same period last year, the firm earned $0.63 EPS. On average, analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Wall Street Analyst Weigh In

WBA has been the topic of a number of recent analyst reports. UBS Group reiterated a "neutral" rating on shares of Walgreens Boots Alliance in a research note on Thursday, June 26th. Wall Street Zen began coverage on Walgreens Boots Alliance in a report on Wednesday, May 21st. They issued a "hold" rating for the company. Finally, Morgan Stanley reissued an "underweight" rating on shares of Walgreens Boots Alliance in a report on Thursday, June 26th. One equities research analyst has rated the stock with a Buy rating, six have assigned a Hold rating and four have given a Sell rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Reduce" and a consensus target price of $10.15.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.